Delivery Order SPE2DR25D2014-SPE2DR26FZ64A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,766.20. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,059.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of July 23, 2025. This non-set-aside competitive award represents a single delivery order transaction for pharmaceutical supplies to support federal medical procurement needs, with performance executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,685.41 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Humalog 200 Unit/mL KwikPen 3mL insulin pens. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,098.24 under a firm fixed price arrangement, with an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $5,887.90. This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-compete, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens, valued at $1,335.60 with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $39,260.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award was issued on September 18, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the broader federal pharmaceutical supply chain...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $1,161.14. This non-set-aside contract is priced on a firm fixed price basis and represents a purchase of insulin medication for military healthcare programs. The award was made on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ64ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,026.00. The contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The pharmaceutical supply supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contract mechanism, with DLA planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts that will involve multiple awards across separate regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/6/25 |